Featuring articles on deaths due to e-cigarette– or vaping-associated lung injury, apixaban for venous thromboembolism in cancer, the management of coronary disease in patients with advanced kidney disease, health-status outcomes in the ISCHEMIA-CKD trial, and ten weeks to crush the curve.
Additionally, renin–angiotensin–aldosterone system inhibitors in patients with Covid-19, and teasing the immune system to repair the heart; a review article on the care of patients with diabetic retinopathy; a case report of a man with high blood pressure, renal insufficiency, and hematuria; and Perspective articles on clinical and social risk adjustment, on prediction models, and on medical care during the pandemic.
Doctors are delaying procedures and surgeries in order to save resources like hospital beds and ventilators for Covid-19 patients, and prevent the infection from spreading.
To reopen the economy safely, experts estimate the U.S. will need to administer millions of tests every month.
Donald G. McNeil Jr.
Cardiovascular consults are way down. Is the threat of COVID-19 infection scaring people away from ED’s?
A selection of three essential articles read aloud from the latest issue of The Economist. This week, is 
When a man returning from Wuhan, China in January 2020 exhibited symptoms of the novel coronavirus, public health officials in the Seattle area were already on alert. 
Intellicurious 